Proposals about medical cannabis in New Zealand
Introduction
The New Zealand government has issued a request for proposals to provide doctors from the nation with a manual on medicinal marijuana and its use as medicine. The government expects the resulting publication or educational resource to provide health professionals a starting point to understand cannabis and its medical uses. Improved medical education is considered an important step for the local market, including companies, reaching its potential.
Developing
New Zealand launched its medical cannabis program earlier this year. The Ministry of Health said that the resource will provide health professionals basic information about cannabis when filling a void for doctors who do not have the information they need to make effective clinical decisions. ‘This resource will be aim.
The total financing available for the project is 50.000 New Zealand dollars (33.300 dollars). The new publication does not intend to provide a clinical guide. A group that represents organizations in the medical marijuana sector welcomed the proposal, but suggested that it does not go far enough. ‘The industry includes and respects the independence of health professionals and does not want to give the impression of an inappropriate influence, but in this space of rapid movement research.
Many prescribers do not have adequate information and education about cannabis -based medications, ’. He said that the industry wants to share what has been learned about the medicinal cannabis ‘within the appropriate parameters’, but companies can only respond to requests for information not requested from health professionals and participate in scientific conferences.
You may be interested: she said: "It’s a sinister trick and a huge barrier for health professionals’. ‘What the NZMCC really expects is some freedom to support health professionals with the most recent scientific information, continuous medical research, education and training’. Zoe Reece, founder and executive director of the local firm of Cannabis Ora Pharm.
conclusion
‘However, there is uncertainty about when the development of clinical guides will be carried out,’ he said. ‘Education without a clear clinical prescription guideline can inhibit medical professionals to prescribe medical cannabis and can contribute to a slow assimilation of the product by the New Zealand public’. ‘Regardless, this is a great step forward to help make the industry and understand the medical cannabis through the education of medical professionals’. The deadline for sending a proposal is November 13, 2020.
Leave feedback